BARCLAYS PLC - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 87 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2022. The put-call ratio across all filers is 5.07 and the average weighting 0.7%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q3 2023$3,376
-71.4%
65,055
-67.0%
0.00%
-71.4%
Q2 2023$11,821
+17.8%
197,141
-2.9%
0.01%
+40.0%
Q1 2023$10,036
-10.8%
202,984
+3.0%
0.01%0.0%
Q4 2022$11,250
-64.8%
197,128
+29234.5%
0.01%
Q3 2022$32,000
+10.3%
672
-13.4%
0.00%
Q2 2022$29,000
-12.1%
776
-30.0%
0.00%
Q1 2022$33,0001,1080.00%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q3 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$34,592,30327.53%
RTW INVESTMENTS, LP 6,029,633$361,536,7956.88%
Paradigm Biocapital Advisors LP 1,270,124$76,156,6355.88%
Rock Springs Capital Management LP 3,028,410$181,583,4644.32%
Logos Global Management LP 500,000$29,980,0004.08%
TANG CAPITAL MANAGEMENT LLC 405,600$24,319,7763.58%
GREAT POINT PARTNERS LLC 297,082$17,813,0373.49%
Eschler Asset Management LLP 34,000$2,038,6402.89%
COWEN AND COMPANY, LLC 460,036$27,583,7582.29%
HighVista Strategies LLC 44,094$2,643,8761.21%
View complete list of IMMUNOCORE HLDGS PLC shareholders